The open index of psychedelic research

Response to: Swieczkowski D, Kwaśny A, Cubała WJ. Regulatory context for protocol amendments and public reporting in psychedelic trials.

Žuljević MF, Mijatović A, Orhanović R +2

[Opioid insensitivity associated with genetic variants in the μ-opioid receptor].

Lund A, Djursby M, Jæger P +1

InTRavenous kEtAmine and immerSive virtUal Reality to Treat dEpression

Effects of psychedelic use on authoritarian attitudes revisited.

Simonsson O, Lyons T, Marks J +5

5-HT<sub>1A</sub> receptor blockade potentiates the subjective effects of DMT.

Zahid Z, Strassman RJ, Qualls CR +1

Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery

Tanaka M

Multimodal Anesthesia in Robotic Laparoscopic Nephrectomy

N,N-Dimethyltryptamine (DMT) Acutely Exposed to Mouse Ventral Tegmental Area I<sub>h</sub>-Negative Neurons Alters the Firing Rate and Conductance in a Sex-Dependent Manner.

Eliasen JN, Rezagholizadeh A, Jacobsen HP +1

Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies

New Approach Methodologies and Open Access Tools Help Characterize Risks for DART, DNT, or Endocrine Effects From Exposure to Hallucinogens With Potential Pesticide Contaminants.

Silva MH

Investigating Hypo-Egoic Features: Ayahuasca's Psychedelic Path Versus Meditation's Mindful Journey.

Arqueros M, Soler J, Cebolla A +3

Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression: A Randomized Clinical Trial.

Yngwe H, Plavén-Sigray P, Ekman CJ +5

Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression: The EPISODE Randomized Clinical Trial.

Mertens LJ, Koslowski M, Betzler F +23

Psilocin glucuronide in whole blood: a stable and useful biomarker of psilocybin intake.

Bergh MS, Bogen IL, Vevelstad M +1

The Improvement of Low-dose Esketamine on Postoperative Depression in Patients Undergoing Bariatric Surgery With Preoperative Depression

Higher Neutrophil-to-Lymphocyte Ratio Is Associated With Better Response to Esketamine in Treatment-Resistant Depression: A Post Hoc Exploratory Analysis of Real-World Data.

Carminati M, Tondello M, Morana C +2

Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder

Understanding Music and Mindfulness Preferences in Psilocybin-Assisted Psychotherapy

A comprehensive review of the clinical progress of esketamine: From anesthesia to antidepressant therapy.

Hu HL, Huang QZ, Xie PX

Pharmacotherapeutic Management of Depression in Patients With Cancer: A Review of Mechanistic and Clinical Evidence.

Hajivalizadeh S, Farahmand K, Kazemzadeh K +2

Olanzapine for young people with anorexia nervosa: a synopsis of the main results from the OPEN open-label feasibility study.

Filiz ES, Stringer D, Kellermann V +27

Distinct therapeutic profiles of ketamine in treatment-resistant depression: an exploratory analysis.

Liu KI, Lin WC, Li CT +3

My Lifelong Search for Relief From Obsessive-Compulsive Disorder and My Hope in Novel Treatments.

Milan R

TrkB/mGluR5 cross-talk underlies a synaptic metaplasticity mechanism of ketamine.

Arefin A, Kim J, Chakraborty MP +4